{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:52:38Z","timestamp":1793242358690,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["NRF-2021R1A2C1003297"],"award-info":[{"award-number":["NRF-2021R1A2C1003297"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ejphar.2025.178371","type":"journal-article","created":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T20:24:11Z","timestamp":1763324651000},"page":"178371","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Activation of autophagy as a strategy to overcome Osimertinib-resistance in non-small cell lung cancer"],"prefix":"10.1016","volume":"1008","author":[{"given":"Ye Won","family":"Jang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woom-Yee","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Min","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Sun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9132-1277","authenticated-orcid":false,"given":"Ja-Eun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo-Won","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.178371_bib1","doi-asserted-by":"crossref","first-page":"30787","DOI":"10.18632\/oncotarget.5021","article-title":"Colorectal cancer-related mutant KRAS alleles function as positive regulators of autophagy","volume":"6","author":"Alves","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2025.178371_bib2","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1182\/blood-2016-07-692707","article-title":"Autophagy, a key mechanism of oncogenesis and resistance in leukemia","volume":"129","author":"Auberger","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2025.178371_bib3","doi-asserted-by":"crossref","first-page":"47232","DOI":"10.18632\/oncotarget.10030","article-title":"Zingerone suppresses angiogenesis via inhibition of matrix metalloproteinases during tumor development","volume":"7","author":"Bae","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2025.178371_bib4","doi-asserted-by":"crossref","first-page":"848","DOI":"10.21037\/atm.2020.04.17","article-title":"Hitting the brakes on autophagy for overcoming acquired resistance in triple negative breast cancer","volume":"8","author":"Bellio","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ejphar.2025.178371_bib5","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2217\/fon-2018-0626","article-title":"Role of osimertinib in the treatment of EGFR-mutation positive non-small-cell lung cancer","volume":"15","author":"Carlisle","year":"2019","journal-title":"Future Oncol."},{"key":"10.1016\/j.ejphar.2025.178371_bib6","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/crj.13091","article-title":"Metformin-sensitized NSCLC cells to osimertinib via AMPK-dependent autophagy inhibition","volume":"13","author":"Chen","year":"2019","journal-title":"Clin. Res. J"},{"key":"10.1016\/j.ejphar.2025.178371_bib7","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1158\/2159-8290.CD-14-0337","article-title":"AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer","volume":"4","author":"Cross","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ejphar.2025.178371_bib8","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ymeth.2007.11.008","article-title":"Analysis of apoptosis by cytometry using TUNEL assay","volume":"44","author":"Darzynkiewicz","year":"2008","journal-title":"Methods"},{"key":"10.1016\/j.ejphar.2025.178371_bib9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/sita.200500073","article-title":"Polyethylenimine, a cost-effective transfection reagent","volume":"6","author":"Ehrhardt","year":"2006","journal-title":"Signal Transduct."},{"key":"10.1016\/j.ejphar.2025.178371_bib10","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/JTO.0b013e31825581bd","article-title":"The mTOR pathway in lung cancer and implications for therapy and biomarker analysis","volume":"7","author":"Ekman","year":"2012","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.ejphar.2025.178371_bib11","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1200\/JCO.2010.33.4235","article-title":"Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin\/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer in Asia (IPASS)","volume":"29","author":"Fukuoka","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2025.178371_bib12","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.4161\/cbt.22002","article-title":"EGFR tyrosine kinase inhibition induces autophagy in cancer cells","volume":"13","author":"Fung","year":"2012","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.ejphar.2025.178371_bib13","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1177\/09603271211030554","article-title":"EGFR tyrosine kinase inhibitor Almonertinib induces apoptosis and autophagy mediated by reactive oxygen species in non-small cell lung cancer cells","volume":"40","author":"Ge","year":"2021","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.ejphar.2025.178371_bib14","first-page":"981","article-title":"[EGFR tyrosine kinase inhibitor HS-10296 induces autophagy and apoptosis in triplenegative breast cancer MDA-MB-231 cells]","volume":"40","author":"Ge","year":"2020","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"10.1016\/j.ejphar.2025.178371_bib15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.canlet.2011.07.002","article-title":"Combining an EGFR directed tyrosine kinase inhibitor with autophagy-inducing drugs: a beneficial strategy to combat non-small cell lung cancer","volume":"310","author":"Gorzalczany","year":"2011","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejphar.2025.178371_bib16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s40265-015-0533-4","article-title":"Osimertinib: first global approval","volume":"76","author":"Greig","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2025.178371_bib17","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1111\/1759-7714.13925","article-title":"Quercetin induces pro-apoptotic autophagy via SIRT1\/AMPK signaling pathway in human lung cancer cell lines A549 and H1299 in vitro","volume":"12","author":"Guo","year":"2021","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.ejphar.2025.178371_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018691","article-title":"EGFR tyrosine kinase inhibitors activate autophagy as a cytoprotective response in human lung cancer cells","volume":"6","author":"Han","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2025.178371_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9040027","article-title":"EGFR family members' regulation of autophagy is at a crossroads of cell survival and death in cancer","volume":"9","author":"Henson","year":"2017","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejphar.2025.178371_bib20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0140-6736(16)30958-8","article-title":"Lung cancer: current therapies and new targeted treatments","volume":"389","author":"Hirsch","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2025.178371_bib21","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1200\/JCO.2003.11.069","article-title":"Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis","volume":"21","author":"Hirsch","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2025.178371_bib22","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1038\/s41598-017-04258-8","article-title":"Blocking autophagy improves the anti-tumor activity of afatinib in lung adenocarcinoma with activating EGFR mutations in vitro and in vivo","volume":"7","author":"Hu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.178371_bib23","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41419-017-0166-5","article-title":"Honokiol induces apoptosis and autophagy via the ROS\/ERK1\/2 signaling pathway in human osteosarcoma cells in vitro and in vivo","volume":"9","author":"Huang","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2025.178371_bib24","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJMoa1411817","article-title":"AZD9291 in EGFR inhibitor\u2013resistant Non\u2013Small-Cell lung cancer","volume":"372","author":"J\u00e4nne","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2025.178371_bib25","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41419-020-02849-4","article-title":"Ischemia induces autophagy of endothelial cells and stimulates angiogenic effects in a hindlimb ischemia mouse model","volume":"11","author":"Jeong","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2025.178371_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18020321","article-title":"Concurrent autophagy inhibition overcomes the resistance of epidermal growth factor receptor tyrosine kinase inhibitors in human bladder cancer cells","volume":"18","author":"Kang","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.178371_bib27","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1126\/science.290.5497.1717","article-title":"Autophagy as a regulated pathway of cellular degradation","volume":"290","author":"Klionsky","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2025.178371_bib28","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.1158\/1078-0432.CCR-06-0714","article-title":"Analysis of epidermal growth factor receptor gene mutation in patients with non-small cell lung cancer and acquired resistance to gefitinib","volume":"12","author":"Kosaka","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2025.178371_bib29","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1002\/cncr.35128","article-title":"Lung cancer statistics, 2023","volume":"130","author":"Kratzer","year":"2024","journal-title":"Cancer"},{"key":"10.1016\/j.ejphar.2025.178371_bib30","doi-asserted-by":"crossref","first-page":"7665","DOI":"10.1073\/pnas.0502860102","article-title":"Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib","volume":"102","author":"Kwak","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2025.178371_bib31","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41416-019-0573-8","article-title":"Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer","volume":"121","author":"Leonetti","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejphar.2025.178371_bib32","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cellsig.2017.04.012","article-title":"The roles of subcellularly located EGFR in autophagy","volume":"35","author":"Li","year":"2017","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejphar.2025.178371_bib33","article-title":"Resveratrol induces autophagy and apoptosis in non-small-cell lung cancer cells by activating the NGFR-AMPK-mTOR pathway","volume":"14","author":"Li","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.ejphar.2025.178371_bib34","first-page":"1213","article-title":"Targeting autophagy is a promising therapeutic strategy to overcome chemoresistance and reduce metastasis in osteosarcoma","volume":"55","author":"Liao","year":"2019","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejphar.2025.178371_bib35","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1172\/JCI70454","article-title":"Targeting ER stress-induced autophagy overcomes BRAF inhibitor resistance in melanoma","volume":"124","author":"Ma","year":"2014","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2025.178371_bib36","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1056\/NEJMoa0909530","article-title":"Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR","volume":"362","author":"Maemondo","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2025.178371_bib37","doi-asserted-by":"crossref","first-page":"6550","DOI":"10.1038\/sj.onc.1204082","article-title":"The EGF receptor family as targets for cancer therapy","volume":"19","author":"Mendelsohn","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2025.178371_bib38","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s12272-021-01312-y","article-title":"Mechanisms of resistance to chemotherapy in non-small cell lung cancer","volume":"44","author":"Min","year":"2021","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.ejphar.2025.178371_bib39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1470-2045(09)70364-X","article-title":"Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial","volume":"11","author":"Mitsudomi","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ejphar.2025.178371_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.761080","article-title":"p53 modulation of autophagy signaling in cancer therapies: perspectives mechanism and therapeutic targets","volume":"10","author":"Rahman","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejphar.2025.178371_bib41","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1634\/theoncologist.2009-0054","article-title":"The role of EGFR inhibition in the treatment of non-small cell lung cancer","volume":"14","author":"Ray","year":"2009","journal-title":"Oncologist"},{"key":"10.1016\/j.ejphar.2025.178371_bib42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jviromet.2006.07.024","article-title":"Transfection of mammalian cells using linear polyethylenimine is a simple and effective means of producing recombinant adeno-associated virus vectors","volume":"138","author":"Reed","year":"2006","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.ejphar.2025.178371_bib43","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/ijc.24030","article-title":"Inhibition of autophagy at a late stage enhances imatinib-induced cytotoxicity in human malignant glioma cells","volume":"124","author":"Shingu","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejphar.2025.178371_bib44","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/2045-3701-3-35","article-title":"Paradoxical roles of autophagy in different stages of tumorigenesis: protector for normal or cancer cells","volume":"3","author":"Sun","year":"2013","journal-title":"Cell Biosci."},{"key":"10.1016\/j.ejphar.2025.178371_bib45","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejphar.2025.178371_bib46","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.taap.2017.02.017","article-title":"Osimertinib induces autophagy and apoptosis via reactive oxygen species generation in non-small cell lung cancer cells","volume":"321","author":"Tang","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178371_bib47","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","article-title":"The 2015 world health organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification","volume":"10","author":"Travis","year":"2015","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.ejphar.2025.178371_bib48","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12931-024-02844-9","article-title":"Combination of betulinic acid and EGFR-TKIs exerts synergistic anti-tumor effects against wild-type EGFR NSCLC by inducing autophagy-related cell death via EGFR signaling pathway","volume":"25","author":"Wang","year":"2024","journal-title":"Respir. Res."},{"key":"10.1016\/j.ejphar.2025.178371_bib49","doi-asserted-by":"crossref","first-page":"66944","DOI":"10.18632\/oncotarget.11396","article-title":"Berberine induces autophagy in glioblastoma by targeting the AMPK\/mTOR\/ULK1-pathway","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2025.178371_bib50","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13045-016-0268-z","article-title":"Third-generation inhibitors targeting EGFR T790M mutation in advanced non-small cell lung cancer","volume":"9","author":"Wang","year":"2016","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ejphar.2025.178371_bib51","doi-asserted-by":"crossref","first-page":"7025","DOI":"10.1021\/jm400822z","article-title":"Structure- and reactivity-based development of covalent inhibitors of the activating and gatekeeper mutant forms of the epidermal growth factor receptor (EGFR)","volume":"56","author":"Ward","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2025.178371_bib52","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.cell.2013.08.015","article-title":"EGFR-mediated Beclin 1 phosphorylation in autophagy suppression, tumor progression, and tumor chemoresistance","volume":"154","author":"Wei","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2025.178371_bib53","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1172\/JCI73941","article-title":"The role for autophagy in cancer","volume":"125","author":"White","year":"2015","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2025.178371_bib54","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.canlet.2019.10.030","article-title":"EGFR-mediated autophagy in tumourigenesis and therapeutic resistance","volume":"469","author":"Wu","year":"2020","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.ejphar.2025.178371_bib55","article-title":"Synergistic augmentation of osimertinib-induced autophagic death by proguanil or rapamycin in bladder cancer","volume":"2020","author":"Xiao","year":"2023","journal-title":"MedComm"},{"key":"10.1016\/j.ejphar.2025.178371_bib56","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1254\/jphs.13085FP","article-title":"Curcumin induces autophagy via activating the AMPK signaling pathway in lung adenocarcinoma cells","volume":"123","author":"Xiao","year":"2013","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2025.178371_bib57","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/cam4.150","article-title":"Therapeutic potential and adverse events of everolimus for treatment of hepatocellular carcinoma - systematic review and meta-analysis","volume":"2","author":"Yamanaka","year":"2013","journal-title":"Cancer Med."},{"key":"10.1016\/j.ejphar.2025.178371_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010179","article-title":"The dual role of autophagy in cancer development and a therapeutic strategy for cancer by targeting autophagy","volume":"22","author":"Yun","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.178371_bib59","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-019-0731-8","article-title":"Emerging therapies for non-small cell lung cancer","volume":"12","author":"Zhang","year":"2019","journal-title":"J. Hematol. Oncol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925011252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925011252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T15:25:53Z","timestamp":1773329153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925011252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":59,"alternative-id":["S0014299925011252"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178371","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activation of autophagy as a strategy to overcome Osimertinib-resistance in non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178371","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"178371"}}